Press Releases

Recro Pharma Presents Clinical Data at American Pain Society 35th Annual Scientific Meeting

May 12, 2016

Recro Pharma Reports Year End 2015 Financial Results

March 24, 2016

Recro Pharma to Present at the 28th Annual ROTH Conference

March 7, 2016

Recro Pharma Appoints Fred Graff as Chief Commercial Officer

February 16, 2016

Recro Pharma Initiates Second Pivotal Phase III Clinical Trial of IV Meloxicam for Acute Postoperative Pain

February 1, 2016

Recro Pharma Initiates Pivotal Phase III Clinical Trial of IV Meloxicam for Acute Postoperative Pain

January 27, 2016

Recro Pharma to Present at NobleCon12 Investor Conference

January 14, 2016

Recro Pharma Reports Positive Top-Line Results for Phase II Clinical Trial of IV Meloxicam

January 6, 2016

Recro Pharma Appoints Stewart McCallum, MD, as Chief Medical Officer

December 2, 2015

Recro Pharma to Present at the 2015 Piper Jaffray Healthcare Conference

November 24, 2015